ARTICLE | Company News
Cubist other research news
November 19, 2001 8:00 AM UTC
CBST received two SBIR grants from the National Institute of Allergy and Infectious Diseases totaling $1.25 million. Under a 2-year Phase II SBIR, the company will identify and screen small molecules ...